| Patient Education |
|
Click here for patient education.
|
|
You are in: eMedicine Specialties >
Emergency Medicine > CARDIOVASCULAR
Mesenteric Ischemia
Article Last Updated: Jul 15, 2008
AUTHOR AND EDITOR INFORMATION
Section 1 of 11
Author: Daniel K Nishijima, MD, Staff Physician, Department of Emergency Medicine, State University of New York Downstate at Brooklyn/Kings County Medical Center
Daniel K Nishijima is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Coauthor(s):
Mark Su, MD, FACEP, FACMT, Consulting Staff and Director of Fellowship in Medical Toxicology, Department of Emergency Medicine, North Shore University Hospital; Consulting Staff, North Shore University Hospital
Editors: Robert M McNamara, MD, FAAEM, Chair and Professor, Department of Emergency Medicine, Temple University School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Gary Setnik, MD, Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Associate-Chief, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital
Author and Editor Disclosure
Synonyms and related keywords:
acute mesenteric ischemia, AMI, chronic mesenteric ischemia, CMI, interruption of blood flow to small intestine, arterial mesenteric ischemia, venous mesenteric ischemia, superior mesenteric artery occlusion, nonocclusive infarction, inferior mesenteric artery occlusion, mesenteric venous thrombosis, arteritis
Background
Mesenteric ischemia is a relatively rare disorder seen in the emergency department (ED); however, it is an important diagnosis to make because of its high mortality rate. Vague and nonspecific clinical findings and limitations of diagnostic studies make the diagnosis a significant challenge. Moreover, delays in diagnosis lead to increased mortality rates. Despite recent advances in diagnosis and treatment, mortality rates continue to remain high.
Pathophysiology
Mesenteric ischemia is caused by decreased intestinal blood flow that can be caused by a number of mechanisms. Decreased intestinal blood flow results in ischemia and subsequent reperfusion damage at the cellular level that may progress to the development of mucosal injury, tissue necrosis, and metabolic acidosis.
The blood supply to the intestine is derived predominantly from 3 major gastrointestinal arteries that arise from the abdominal aorta: the celiac axis, the superior mesenteric artery (SMA), and the inferior mesenteric artery (IMA). The intestine has significant collateral circulation at all levels that allows for some protection from ischemia and is able to compensate for approximately a 75% acute reduction in mesenteric blood flow for up to 12 hours, without substantial injury.
The pathophysiology of intestinal ischemia can be divided into arterial and venous etiologies and acute and chronic ischemia. The vast majority of cases are secondary to arterial causes. All diseases and conditions that affect arteries, including atherosclerosis, arteritis, aneurysms, arterial infections, dissections, arterial emboli, and thrombosis, are reported to occur in the intestinal arteries.
Acute mesenteric ischemia (AMI) can be further divided into embolic, thrombotic, or nonocclusive causes.
- Arterial embolism
- Arterial embolism accounts for approximately one third of acute cases of AMI.
- Emboli to the mesenteric arteries are usually from a dislodged cardiac thrombus.
- The SMA is most commonly affected with the IMA rarely affected due to its small caliber.
- Arterial thrombosis
- Arterial thrombosis accounts for approximately one third of acute cases of AMI.
- It is usually due to acute worsening of ischemia in patients who have preexisting atherosclerosis of the mesenteric arteries.
- Thrombosis often involves at least 2 of the major splanchnic vessels.
- Nonocclusive etiology
- Nonocclusive etiology accounts for approximately one third of acute cases of AMI.
- The primary mechanism is severe and prolonged intestinal vasoconstriction.
- The most common setting is severe systemic illness with systemic shock usually secondary to reduced cardiac output.
- Intestinal vasospasm has also been seen to occur in cocaine ingestion, ergot poisoning, digoxin use, and with alpha-adrenergic agonists.
- A small proportion of cases are from venous thrombosis, seen mostly in patients with hypercoagulable states.
- Venous thrombosis of the visceral vessels may precipitate an acute ischemic event as compromised venous return leads to interstitial swelling of the bowel wall, with subsequent impedance of arterial flow and eventual tissue necrosis.
Chronic mesenteric ischemia (CMI) usually results from long-standing atherosclerotic disease of 2 or more mesenteric vessels. Other nonatheromatous causes of CMI include the vasculitides such as Takayasu arteritis. Symptoms are caused by the gradual reduction in blood flow to the intestine that occurs during eating since total blood flow to the intestine can increase by 15% during meals.
Frequency
United States
AMI is involved in up to 0.1% of all hospital admissions, although this number is likely to rise as the population ages.
Mortality/Morbidity
- Mortality rates are high and range from 60-100% depending on the source of obstruction. Early and aggressive diagnosis and treatment has been shown to significantly decrease the mortality rate if the diagnosis is made prior to the development of peritonitis.
- One report of 21 patients with SMA embolus, intestinal viability was achieved in 100% of patients before diagnosis if the duration of symptoms was less than 12 hours, in 56% if it was between 12 and 24 hours, and in only 18% if symptoms were more than 24 hours in duration.
- Another study found that even at hospital centers with angiography available 24 hours, mortality rates still were approximately 70%.
Sex
No sex predilection exists.
Age
Mesenteric ischemia is generally a disease of the older population, with the typical age of onset being older than 60 years; however, with risk factors and other predisposing factors, it may be seen in younger patients.
History
- The clinical presentation is largely dependent on the underlying etiology, with AMI and CMI presenting very differently.
- The classic picture of a patient with AMI involves severe abdominal pain with a paucity of significant abdominal findings in patients with significant underlying risk factors.
- Because the pathologic process is ischemia, the pain is initially visceral in nature and generally poorly localized.
- Acute pain may occur if an embolus is the cause, but it is essential to remember that a gradual onset of pain is more common in the overall spectrum of mesenteric ischemia.
- The pain is usually severe and may occasionally be refractory to opioid analgesics.
- Prior episodes of a similar pain, often related to meals (intestinal angina), may be reported.
- Abdominal pain may be absent in 15-25% of cases; associated GI symptoms are common and caution must be taken to not be misled.
- Nausea and vomiting are frequent, and diarrhea may occur in as many as 50% of patients with mesenteric ischemia.
- The classic triad of SMA embolism includes GI emptying, abdominal pain, and underlying cardiac disease.
- Chronic mesenteric ischemia typically causes postprandial abdominal pain and weight loss that results in chronic dull pain as the obstructive process worsens.
- Patients with chronic mesenteric ischemia may also report sitophobia (fear of eating).
Physical
- The sine qua non of mesenteric ischemia is a relatively normal abdominal examination in the face of severe abdominal pain.
- Advanced ischemia may be signified by increasing abdominal distention, ileus, frank peritonitis, and shock.
- Theoretically, before the onset of significant mucosal injury, blood in the GI tract should be absent early in the disease process.
- Melena or hematochezia occurs in 15% of cases, and occult blood is detected in approximately 50% of patients.
Causes
- Acute arterial embolus: Embolic lesions are usually secondary to conditions that predispose the patient to embolus formation such as atrial fibrillation, ventricular aneurysm, and valvular disease.
- Acute arterial thrombosis
- Acute arterial thrombosis usually occurs following a superimposed insult in patients with preexisting atherosclerosis.
- Other causes include aortic aneurysm, aortic dissection, and arteritis.
- Nonocclusive ischemia
- The causes of nonocclusive mesenteric ischemia include all of the causes of splanchnic vasoconstriction including hypovolemia, cardiac shock, sepsis, alpha-agonism, ergots, cocaine, and digitalis.
- Case reports exist of marathon runners developing ischemic colitis following a marathon that resolved in most runners with supportive treatment.
- Mesenteric venous thrombosis
- Approximately 75% of patients with mesenteric venous thrombosis have an underlying hypercoagulable state or other risk factors including portal hypertension, intra-abdominal sepsis, cirrhosis, pancreatitis, malignancy, and trauma.
- Oral contraceptive use accounts for 9-18% of the episodes of mesenteric venous thrombosis in young women.
Aneurysm, Abdominal
Appendicitis, Acute
Cholangitis
Cholecystitis and Biliary Colic
Cholelithiasis
Lactic Acidosis
Myocardial Infarction
Obstruction, Large Bowel
Obstruction, Small Bowel
Pancreatitis
Renal Calculi
Shock, Hypovolemic
Other Problems to be Considered
Crohn disease colitis
Ulcerative colitis
Perforated viscus
Appendicitis
Pancreatitis
Diverticulitis
Volvulus
Bowel obstruction
Abdominal aortic aneurysm
Hepatobiliary disease
Lab Studies
- No laboratory test sufficiently rules in or rules out the diagnosis of mesenteric ischemia. Laboratory findings in mesenteric ischemia are nonspecific and generally unreliable.
- Of patients with AMI, 75% have a leukocytosis greater than 15,000 cells/mm3.
- Elevated serum lactate level raises the suspicion of intestinal ischemia; however, elevation of lactate is often a late finding. One small study found that increased plasma lactate concentration had a sensitivity of 96% (24/25) for recognizing AMI in patients with abdominal complaints.
- Several studies have found that serum D-dimer may be used as an early marker for AMI, although it appears to be insensitive.
Imaging Studies
- The American Gastroenterological Association in 2000 released recommended algorithms for the diagnosis and management of mesenteric ischemia (see below). However, this was prior to improved data on multidetector computed tomography (CT) scans, which now have a greater role in the diagnosis of mesenteric ischemia.
- Plain films
- Plain abdominal radiographs are generally normal or nonspecific and therefore should not be used to rule out mesenteric ischemia. Thumbprinting, pneumatosis intestinalis, or portal venous gas raises the suspicion for mesenteric ischemia, though these are findings that are found later in the disease process.
- Plain films are best used for rapid identification of intestinal obstruction or perforation and to hasten surgical intervention.
- CT scan
- Multidetector row CT has emerged as a valuable tool for the evaluation of mesenteric ischemia. Multidetector row CT and 3-dimensional imaging provide a detailed examination of small bowel and mesenteric vessels. Multiple studies have shown a sensitivity ranging from 96-100% and specificity ranging from 89-94%. Findings of AMI included mesenteric arterial or venous thrombus, mesenteric venous gas, pneumatosis intestinalis, bowel-wall thickening, increased or decreased enhancement of the bowel wall, bowel dilatation, mesenteric or perienteric fat stranding, ascites, pneumoperitoneum, and solid organ infarction.
- CT scan of the abdomen is the diagnostic test of choice if suspicion for mesenteric venous thrombosis is high; sensitivities are greater than 90%. CT findings include a central lucency in the mesenteric vein, enlargement of the superior mesenteric vein, and a sharply defined vein wall with a rim of increased density.
- Angiography
- For many years, angiography has been considered to be the criterion standard for the diagnosis of acute arterial occlusion.
- Abrupt cutoff of the SMA with the absence of collateral circulation is diagnostic, with nearly 100% sensitivity in acute embolic occlusion.
- Angiography has the added advantage of therapeutic options as well, including administration of intra-arterial thrombolytic agents for acute arterial thrombosis as well as intra-arterial papaverine infusion for all types of arterial ischemia.
- The disadvantages of angiography are that it is highly invasive and is not suitable in critically ill patients, often is not readily available and may delay surgical management, and nephrotoxicity may occur due to the effects of intravenous contrast on the kidneys. Angiography also has a relatively high false-negative rate in patients presenting early in the course of the disease.
- Despite the disadvantages, if suspicion for AMI is high, the EP should aggressively pursue angiography as the diagnostic study of choice.
- Prompt laparotomy is indicated in patients with suspected AMI in whom expeditious angiography is not available.
- If suspicion of mesenteric venous thrombosis is high, such as in a patient with a history of hypercoagulable state, angiography is not indicated. CT scan of the abdomen is the diagnostic test of choice in this situation.
- MRI
- MRI has been evaluated for the diagnosis of CMI and has been shown to have accurate imaging of the mesenteric vasculature. However, in the acute setting, MRI does not have much benefit over CT imaging.
- MRI should not be the initial test in the ED due to time constraints.
- Ultrasonography
- Duplex ultrasonography has shown promising results as a screening tool for the diagnosis of CMI. However, the utility of these tests are largely dependent on operator training, bowel gas patterns, and patient body habitus.
- For all practical purposes, ultrasonography should not be the initial diagnostic choice for the EP.
Procedures
- Nasogastric decompression: The placement of a nasogastric tube is diagnostically useful, both to evaluate the presence of blood, and therapeutically, to relieve distention secondary to ileus.
- The placement of a central line may be useful in hemodynamically unstable patients.
Prehospital Care
- Cardiac monitor, intravenous access, oxygen
- May require intravenous fluid resuscitation
Emergency Department Care
- Resuscitation
- Resuscitation is often needed because patients are usually very toxic or rapidly become toxic.
- Early intubation in unstable patients may improve oxygenation and allow for more aggressive fluid resuscitation.
- Parenteral opioid analgesics
- Parenteral broad-spectrum antibiotics
- All cases of mesenteric ischemia with signs of peritonitis, regardless of the etiology, generally require immediate surgical intervention for the resection of ischemic or necrotic intestines.
- Intra-arterial papaverine during angiography can be used regardless of the etiology of the intestinal ischemia. Papaverine is an opium derivative that functions as a phosphodiesterase inhibitor, which acts to relax vascular smooth muscle. It is usually infused directly into the SMA, thus improving intestinal blood flow.
- Definitive treatment is generally withheld by the EP until an etiology is determined. In cases of mesenteric ischemia, time is of the utmost essence. Treatment options depend on the etiology of intestinal ischemia as well as the hemodynamic stability of the patient.
- Definitive treatment
- For acute arterial embolus, options include papaverine infusion, surgical embolectomy, and intra-arterial thrombolysis.
- For acute arterial thrombosis, options include papaverine infusion and arterial reconstruction either through aortosuperior mesenteric arterial bypass grafting or reimplantation of the SMA to the aorta.
- For nonocclusive mesenteric ischemia, papaverine infusion is the mainstay of treatment.
- For mesenteric venous thrombosis, anticoagulation with heparin/warfarin either alone or in combination with surgery.
- For chronic mesenteric ischemia, management options include angioplasty with or without stent placement or surgical revascularization. Several studies have found a high rate of success with percutaneous stent revascularization for CMI, although repeated interventions may be necessary.
Consultations
- Vascular surgery - Given the need for early diagnosis and treatment, the EP should obtain surgical consultation as soon as the diagnosis is considered.
- Interventional radiology - Angiography and adjunctive treatment
- Intensivist - Patients diagnosed with mesenteric ischemia are often hemodynamically unstable or have a high probability to progress to instability, so most patients require hospitalization in an intensive care unit.
The goals of pharmacotherapy are to reduce morbidity and to prevent complications.
Drug Category: Antibiotic
Therapy must cover all likely pathogens in the context of the clinical setting.
| Drug Name | Clindamycin (Cleocin) |
| Description | Active against anaerobic gram-negative bacilli. Lincosamide useful in treating serious skin and soft tissue infections caused by most staphylococcal strains. Also effective against aerobic and anaerobic streptococci, except enterococci. Inhibits bacterial protein synthesis by inhibiting peptide chain initiation at the bacterial ribosome, which is where it preferentially binds to the 50S ribosomal subunit, causing bacterial growth inhibition. |
| Adult Dose | 400-900 mg IV q8h |
| Pediatric Dose | 9-16 mg/kg/d IV divided tid/qid |
| Contraindications | Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis |
| Interactions | Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis by allowing overgrowth of Clostridium difficile |
| Drug Name | Metronidazole (Flagyl) |
| Description | Imidazole ring-based antibiotic that is active against anaerobes. Usually used in combination with other antimicrobial agents, except when used for C difficile enterocolitis, in which monotherapy is appropriate. |
| Adult Dose | 1 g IV loading dose followed by 0.5 g q6h or 1 g q12h |
| Pediatric Dose | 15-30 mg/kg/d IV divided bid/tid for 7 d, or 40 mg/kg once; not to exceed 2 g/d |
| Contraindications | Documented hypersensitivity |
| Interactions | May increase toxicity of anticoagulants, lithium, and phenytoin; cimetidine may increase toxicity of metronidazole; disulfiramlike reaction may occur with orally ingested ethanol |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy |
| Drug Name | Aztreonam (Azactam) |
| Description | Monobactam that inhibits cell wall synthesis during bacterial growth. Active against aerobic gram-negative bacilli. |
| Adult Dose | 2 g IV q8h |
| Pediatric Dose | 90-120 mg/kg/d IV divided q6-8h |
| Contraindications | Documented hypersensitivity |
| Interactions | Tetracyclines may reduce effects of this medication |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in renal insufficiency |
| Drug Name | Ticarcillin (Ticar, Synthetic Penicillin) |
| Description | Active against aerobic gram-negative bacilli. Inhibits biosynthesis of cell wall mucopeptide, and effective during stage of active growth. |
| Adult Dose | 4 g IV q6h |
| Pediatric Dose | 200-300 mg/kg/d IV divided q4-6h |
| Contraindications | Documented hypersensitivity |
| Interactions | Tetracyclines decrease ticarcillin effects; ticarcillin decreases effect of oral contraceptives; large IV doses can increase risk of bleeding in patients receiving anticoagulants; ticarcillin increases duration of neuromuscular blockers; probenecid increases ticarcillin levels |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Perform CBCs before initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT levels during therapy; urinalysis and BUN and creatinine determinations should be performed during therapy (adjust dose if values become elevated); if renal impairment is known or suspected, adjust dose and monitor blood levels |
| Drug Name | Cefoxitin (Mefoxin) |
| Description | Active against aerobic and anaerobic gram-negative bacilli. Second-generation cephalosporin indicated for management of infections caused by susceptible gram-positive cocci and gram-negative rods. Many infections caused by gram-negative bacteria, which are resistant to some cephalosporins and penicillins, respond to cefoxitin. |
| Adult Dose | 2 g IV q8h |
| Pediatric Dose | <3 months: Not established >3 months: 80-160 mg/kg/d IV divided q4-6h; use higher dosages for more severe or serious infections; not to exceed 12 g/d |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid may increase effects of cefoxitin; coadministration with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function) |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged use or repeated treatment; caution in patients with previously diagnosed colitis |
| Drug Name | Cefotetan (Cefotan) |
| Description | Active against aerobic and anaerobic gram-negative bacilli. Second-generation cephalosporin indicated for management of infections caused by susceptible gram-positive cocci and gram-negative rods. Determine proper dosage and route of administration by condition of the patient, severity of the infection, and susceptibility of the causative organism. |
| Adult Dose | 1-2 g IV q12h |
| Pediatric Dose | 20-40 mg/kg/dose IV q12h for 5-10 d |
| Contraindications | Documented hypersensitivity |
| Interactions | Consumption of alcohol within 72 h of cefotetan may produce disulfiramlike reactions; cefotetan may increase hypoprothrombinemic effects of anticoagulants; coadministration with potent diuretics (eg, loop diuretics) or aminoglycosides may increase nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Reduce dosage by one half if CrCl is 10-30 mL/min and by one fourth if <10 mL/min; bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged or repeated therapy |
| Drug Name | Meropenem (Merrem) |
| Description | Bactericidal broad-spectrum carbapenem antibiotic that inhibits cell wall synthesis. Effective against most gram-positive and gram-negative bacteria. |
| Adult Dose | 1 g IV q8h |
| Pediatric Dose | 40 mg/kg IV q8h |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid may inhibit renal excretion of meropenem, increasing meropenem levels |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Pseudomembranous colitis and thrombocytopenia may occur, requiring immediate discontinuation of medication |
Drug Category: Vasodilators
These agents can improve blood supply to ischemic areas.
| Drug Name | Papaverine (Genabid, Pavabid, Pavatine) |
| Description | Benzylisoquinoline derivative. Exerts direct nonspecific relaxant effect on vascular, cardiac, and other smooth muscle. In the absence of peritoneal signs, it is the DOC for AMI of arterial origin if angiogram indicates good distal perfusion. Advocated for treatment of widespread vasoconstriction that follows therapy of SMA emboli by other modalities. |
| Adult Dose | 30-60 mg/h IV |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; complete heart block |
| Interactions | May decrease effectiveness of levodopa |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | Caution in angina, recent MI, recent stroke, and glaucoma |
Further Inpatient Care
- Admit to the ICU.
- Invasive monitoring may be required.
- Broad-spectrum antibiotics should be continued if the diagnosis is confirmed.
- Indications for surgical management of acute or chronic mesenteric ischemia include peritonitis, massive hemorrhage, recurrent fever or sepsis, continuation of symptoms beyond 2-3 weeks, chronic protein-losing colopathy, chronic segmental colitis with ulceration, and symptomatic ischemic stricture.
Transfer
- Transfer is appropriate if the required imaging studies or therapeutic interventions are not available.
Complications
- Sepsis/septic shock
- Multiple system organ failure
- Bowel necrosis requiring resection
- Death
Prognosis
- Mortality rates range from 60-100%, depending on the source of obstruction.
- Predictors of mortality included older age, bandemia, hepatic and renal impairment, hyperamylasemia, metabolic acidosis, hypoxia, intramural pneumatosis, and sepsis.
- With an aggressive diagnostic and therapeutic approach, mortality can be reduced. It is essential to act early on clinical suspicion and not to wait for the development of hard evidence.
Medical/Legal Pitfalls
- Because of the high mortality rate and the difficulty of diagnosis, mesenteric ischemia poses a significant legal risk.
- Legal risk is reduced with high clinical suspicion, early and aggressive diagnostic imaging, and early surgical consult with clear documentation of timing.
- One review of 180 consecutive malpractice claims found 7 cases involving AMI with 5 cases alleging failure to make a timely diagnosis, failure to administer anticoagulation in 1 case, and failure to prevent nonocclusive mesenteric ischemia in 1 case (Fink, 2000).
| Media file 1:
Pneumatosis intestinalis is one of the few radiographic findings in patients with mesenteric ischemia. |
 | View Full Size Image | |
Media type: X-RAY
|
| Media file 2:
Diagnosis and treatment of intestinal ischemia. Solid lines indicate accepted management plan; dashed lines indicate alternate management plan. DVT, deep vein thrombosis; SMA,
superior mesenteric artery. Adapted from Gastroenterology. 2000 May; 118(5): 954-68. |
 | View Full Size Image | |
Media type: Graph
|
| Media file 3:
Diagnosis and treatment of intestinal ischemia. Solid lines indicate accepted management plan; dashed lines indicate alternate management plan. DVT, deep vein thrombosis; SMA,
superior mesenteric artery. Adapted from Gastroenterology. 2000 May; 118(5): 954-68. |
 | View Full Size Image | |
Media type: Graph
|
| Media file 4:
Management of chronic mesenteric ischemia (CMI). Solid lines indicate accepted management plan; dashed lines indicate alternative management plan. MRA, magnetic resonance angiography; CT, computerized tomography. Adapted from Gastroenterology. 2000 May; 118(5): 954-68. |
 | View Full Size Image | |
Media type: Graph
|
| Media file 5:
Management of colon ischemia. Solid lines indicate accepted management plan; dashed lines indicate alternative management plan. BE, barium enema; NPO, nothing by mouth; PLC, protein-losing colopathy; IBD, inflammatory bowel disease.Adapted from Gastroenterology. 2000 May; 118(5): 954-68. |
 | View Full Size Image | |
Media type: Graph
|
- Abdu RA, Zakhour BJ, Dallis DJ. Mesenteric venous thrombosis--1911 to 1984. Surgery. Apr 1987;101(4):383-8. [Medline].
- Agaoglu N, Türkyilmaz S, Ovali E, Uçar F, Agaoglu C. Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia. World J Surg. Sep 2005;29(9):1135-8. [Medline].
- Altinyollar H, Boyabatli M, Berberoglu U. D-dimer as a marker for early diagnosis of acute mesenteric ischemia. Thromb Res. 2006;117(4):463-7. [Medline].
- Boley SJ, Sprayregan S, Siegelman SS, Veith FJ. Initial results from an aggressive roentgenological and surgical approach to acute mesenteric ischemia. Surgery. Dec 1977;82(6):848-55. [Medline].
- Boley SJ. Circulatory responses to acute reduction of superior mesenteric arterial flow. Physiologist. 1969;12:180.
- Boley SJ, Brandt LJ, Sammartano RJ. History of mesenteric ischemia. The evolution of a diagnosis and management. Surg Clin North Am. Apr 1997;77(2):275-88. [Medline].
- Boley SJ, Sprayregen S, Veith FJ, Siegelman SS. An aggressive roentgenologic and surgical approach to acute mesenteric ischemia. Surg Annu. 1973;5:355-78. [Medline].
- Boos S. [Angiography of the mesenteric artery 1976 to 1991. A change in the indications during mesenteric circulatory disorders?]. Radiologe. Apr 1992;32(4):154-7. [Medline].
- Bottger T, Scahafer W, Weber W, Junginger T. Value of preoperative diagnosis in mesenteric vascular occlusion: a prospective study [in German]. Langenbecks Arch Chir. 1990;375:278-282. [Medline].
- Bowersox JC, Zwolak RM, Walsh DB, Schneider JR, Musson A, LaBombard FE. Duplex ultrasonography in the diagnosis of celiac and mesenteric artery occlusive disease. J Vasc Surg. Dec 1991;14(6):780-6; discussion 786-8. [Medline].
- Brandt LJ, Boley SJ. AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology. May 2000;118(5):954-68. [Medline].
- Brown DJ, Schermerhorn ML, Powell RJ, Fillinger MF, Rzucidlo EM, Walsh DB. Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg. Aug 2005;42(2):268-74. [Medline].
- Cappell MS. Intestinal (mesenteric) vasculopathy. I. Acute superior mesenteric arteriopathy and venopathy. Gastroenterol Clin North Am. Dec 1998;27(4):783-825, vi. [Medline].
- Chang JB, Stein TA. Mesenteric ischemia: acute and chronic. Ann Vasc Surg. May 2003;17(3):323-8. [Medline].
- Chang RW, Chang JB, Longo WE. Update in management of mesenteric ischemia. World J Gastroenterol. May 28 2006;12(20):3243-7. [Medline].
- Char D, Hines G. Chronic mesenteric ischemia: diagnosis and treatment. Heart Dis. Jul-Aug 2001;3(4):231-5. [Medline].
- Cikrit DF, Harris VJ, Hemmer CG, Kopecky KK, Dalsing MC, Hyre CE. Comparison of spiral CT scan and arteriography for evaluation of renal and visceral arteries. Ann Vasc Surg. Mar 1996;10(2):109-16. [Medline].
- Clark RA, Gallant TE. Acute mesenteric ischemia: angiographic spectrum. AJR Am J Roentgenol. Mar 1984;142(3):555-62. [Medline].
- Czerny M, Trubel W, Claeys L, Scheuba C, Huk I, Prager M. [Acute mesenteric ischemia]. Zentralbl Chir. 1997;122(7):538-44. [Medline].
- Diamond SM, Emmett M, Henrich WL. Bowel infarction as a cause of death in dialysis patients. JAMA. Nov 14 1986;256(18):2545-7. [Medline].
- Endress C, Gray DG, Wollschlaeger G. Bowel ischemia and perforation after cocaine use. AJR Am J Roentgenol. Jul 1992;159(1):73-5. [Medline].
- Fink S, Chaudhuri TK, Davis HH. Acute mesenteric ischemia and malpractice claims. South Med J. Feb 2000;93(2):210-4. [Medline].
- Gennaro M, Ascer E, Matano R, Jacobowitz IJ, Cunningham JN Jr, Uceda P. Acute mesenteric ischemia after cardiopulmonary bypass. Am J Surg. Aug 1993;166(2):231-6. [Medline].
- Grieshop RJ, Dalsing MC, Cikrit DF, Lalka SG, Sawchuk AP. Acute mesenteric venous thrombosis. Revisited in a time of diagnostic clarity. Am Surg. Sep 1991;57(9):573-7; discussion 578. [Medline].
- Harward TR, Green D, Bergan JJ, Rizzo RJ, Yao JS. Mesenteric venous thrombosis. J Vasc Surg. Feb 1989;9(2):328-33. [Medline].
- Heiss SG, Li KC. Magnetic resonance angiography of mesenteric arteries. A review. Invest Radiol. Sep 1998;33(9):670-81. [Medline].
- Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. Mar 21 2006;113(11):e463-654. [Medline].
- Horton KM, Fishman EK. Multi-detector row CT of mesenteric ischemia: can it be done?. Radiographics. Nov-Dec 2001;21(6):1463-73. [Medline].
- Huang HH, Chang YC, Yen DH, Kao WF, Chen JD, Wang LM. Clinical factors and outcomes in patients with acute mesenteric ischemia in the emergency department. J Chin Med Assoc. Jul 2005;68(7):299-306. [Medline].
- Jona J, Cummins GM, Head HB, Govostis MC. Recurrent primary mesenteric venous thrombosis. JAMA. Mar 4 1974;227(9):1033-5. [Medline].
- Kaufman SL, Harrington DP, Siegelman SS. Superior mesenteric artery embolization: an angiographic emergency. Radiology. Sep 1977;124(3):625-30. [Medline].
- Kirkpatrick ID, Kroeker MA, Greenberg HM. Biphasic CT with mesenteric CT angiography in the evaluation of acute mesenteric ischemia: initial experience. Radiology. Oct 2003;229(1):91-8. [Medline].
- Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. Dec 6 2001;345(23):1683-8. [Medline].
- Kurt Y, Akin ML, Demirbas S, Uluutku AH, Gulderen M, Avsar K. D-dimer in the early diagnosis of acute mesenteric ischemia secondary to arterial occlusion in rats. Eur Surg Res. Jul-Aug 2005;37(4):216-9. [Medline].
- Landis MS, Rajan DK, Simons ME, Hayeems EB, Kachura JR, Sniderman KW. Percutaneous management of chronic mesenteric ischemia: outcomes after intervention. J Vasc Interv Radiol. Oct 2005;16(10):1319-25. [Medline].
- Lange H, Toivola A. Warning signals in acute abdominal disorders. Lactate is the best marker of mesenteric ischemia. Lakartidningen. 1997;May 14; 94(20):1893-6. [Medline].
- Lange H, Jackel R. Usefulness of plasma lactate concentration in the diagnosis of acute abdominal disease. Eur J Surg. Jun-Jul 1994;160(6-7):381-4. [Medline].
- Lauenstein TC, Ajaj W, Narin B, Göhde SC, Kröger K, Debatin JF. MR imaging of apparent small-bowel perfusion for diagnosing mesenteric ischemia: feasibility study. Radiology. Feb 2005;234(2):569-75. [Medline].
- Liu JJ, Ardolf JC. Sumatriptan-associated mesenteric ischemia. Ann Intern Med. Apr 4 2000;132(7):597. [Medline].
- Lobo Martinez E, Merono Carvajosa E, Sacco O, Martinez Molina E. Embolectomy in mesenteric ischemia [in Spanish]. Rev Esp Enferm Dig. May 1993;83(5):351-4. [Medline].
- Moawad J, Gewertz BL. Chronic mesenteric ischemia. Clinical presentation and diagnosis. Surg Clin North Am. Apr 1997;77(2):357-69. [Medline].
- Moneta GL, Yeager RA, Dalman R, Antonovic R, Hall LD, Porter JM. Duplex ultrasound criteria for diagnosis of splanchnic artery stenosis or occlusion. J Vasc Surg. Oct 1991;14(4):511-8; discussion 518-20. [Medline].
- Naitove A, Weismann RE. Primary mesenteric venous thrombosis. Ann Surg. Apr 1965;161:516-23. [Medline].
- Nonthasoot B, Tullavardhana T, Sirichindakul B, Suphapol J, Nivatvongs S. Acute mesenteric ischemia: still high mortality rate in the era of 24-hour availability of angiography. J Med Assoc Thai. Sep 2005;88 Suppl 4:S46-50. [Medline].
- Rhee RY, Gloviczki P, Mendonca CT, Petterson TM, Serry RD, Sarr MG. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg. Nov 1994;20(5):688-97. [Medline].
- Sanchez LD, Tracy JA, Berkoff D, Pedrosa I. Ischemic colitis in marathon runners: a case-based review. J Emerg Med. Apr 2006;30(3):321-6. [Medline].
- Savassi-Rocha PR, Veloso LF. Treatment of superior mesenteric artery embolism with a fibrinolytic agent: case report and literature review. Hepatogastroenterology. Sep-Oct 2002;49(47):1307-10. [Medline].
- Silva JA, White CJ, Collins TJ, Jenkins JS, Andry ME, Reilly JP. Endovascular therapy for chronic mesenteric ischemia. J Am Coll Cardiol. Mar 7 2006;47(5):944-50. [Medline].
- Sreenarasimhaiah J. Diagnosis and management of intestinal ischaemic disorders. BMJ. Jun 21 2003;326(7403):1372-6. [Medline].
- Sudhakar CB, Al-Hakeem M, MacArthur JD, Sumpio BE. Mesenteric ischemia secondary to cocaine abuse: case reports and literature review. Am J Gastroenterol. Jun 1997;92(6):1053-4. [Medline].
- Tambyraja AL. Management of acute mesenteric ischaemia: recommended strategy is misleading. BMJ. Aug 16 2003;327(7411):396; author reply 396. [Medline].
- Vogelzang RL, Gore RM, Anschuetz SL, Blei AT. Thrombosis of the splanchnic veins: CT diagnosis. AJR Am J Roentgenol. Jan 1988;150(1):93-6. [Medline].
- Ward D, Vernava AM, Kaminski DL, Ure T, Peterson G, Garvin P. Improved outcome by identification of high-risk nonocclusive mesenteric ischemia, aggressive reexploration, and delayed anastomosis. Am J Surg. Dec 1995;170(6):577-80; discussion 580-1. [Medline].
- Wiesner W. Is multidetector computerized tomography currently the primary diagnostic method of choice in diagnostic imaging of acute intestinal ischemia? [in German]. Schweiz Rundsch Med Prax. Jul 30 2003;92(31-32):1315-7. [Medline].
- Zeman RK, Silverman PM, Vieco PT, Costello P. CT angiography. AJR Am J Roentgenol. Nov 1995;165(5):1079-88. [Medline].
- Zwolak RM. Can duplex ultrasound replace arteriography in screening for mesenteric ischemia?. Semin Vasc Surg. Dec 1999;12(4):252-60. [Medline].
Mesenteric Ischemia excerpt Article Last Updated: Jul 15, 2008
|